Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Page 1 de 43 résultats
[Keratitis and corneal edema associated with levodopa use--a case report].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
We report a patient who developed keratitis and corneal edema during treatment with carbidopa-levodopa. The patient was a 34-year-old woman who complained of apraxic gait after anoxic brain damage caused by ventricular arrhythmia. She had difficulty in walking. While doses of droxidopa, flecainide
Rigidity and pulmonary edema after Innovar in a patient on Levodopa therapy: report of a case.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
[Idiopathic edema, tubular metabolism of water and sodium].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
OBJECTIVE
To look for intrinsic changes in renal tubular water and sodium metabolism in idiopathic edema (IE), independent of the underlying hormonal and vascular defects.
METHODS
Prospective controlled study in patients with edema referred to a nephrology clinic.
METHODS
Ten female patients with IE
Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The use of levodopa for treatment of Parkinson's disease is a well-established clinical practice. Data about the true incidence and severity of cutaneous complications associated with the use of levodopa are largely lacking. Aim of this review was to evaluate the quality of evidence referring to the
Levodopa treatment of late onset extrapyramidal movements in a child after high voltage electrocution.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
We present the case of a 12-year-old girl with abnormal extrapyramidal movements associated with basal ganglia lesions after electrical injury. After her injury, our patient initially did well and recovered from acute cardiovascular and hemodynamic instability, and the results of her neurological
Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Half of 94 parkinsonian patients improved on amantadine therapy during acute double-blind trials. In a four-year follow-up, amantadine given alone or added to a stable dose of levodopa had its greatest effect in the first month and helped few patients after six months. Levodopa either alone or added
Treatment of experimental cerebral infarction in rats with levodopa or with glycerol.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Administration of large amounts of levodopa did not improve survival rates of rats after acute cerebral infarction induced by injection of carbon microspheres. However, when 10% glycerol was used, the number of rats that survived after cerebral infarction was significantly greater than in the
[Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
A 77-year-old woman was admitted to our department due to leg edema of 2-year duration. The patient has been suffered from Parkinson's disease for 12 years and prescribed levodopa, selegiline, and small dosage of pergolide (200 microg/day). Leg edema developed one year after she took pergolide.
[Severe leg edema associated with the use of dopaminergic drugs in Parkinson's disease. Report of one case].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The main adverse effects of dopaminergic drugs used in Parkinson's disease are hypotension, somnolence, hallucinations and impulse control disorder. Less common is leg edema. We report on a 68-year-old male receiving levodopa and pramipexole consulting for severe leg edema lasting two years, whose
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
The best way to initiate dopaminergic therapy for early Parkinson disease remains unclear.
OBJECTIVE
To compare initial treatment with pramipexole vs levodopa in early Parkinson disease, followed by levodopa supplementation, with respect to the development of dopaminergic motor
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
The CALM-PD trial evaluated the development of motor complications in subjects with early Parkinson disease (PD) randomized to initial treatment with either pramipexole or levodopa. A secondary finding of the trial was a higher than anticipated development or worsening of somnolence and
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Medical treatment of levodopa-induced dyskinesia (LID) in Parkinson's disease (PD) is an unmet need. ADS-5102 (amantadine) extended-release capsules is being developed for the treatment of LID in patients with PD.
Evaluate the long-term safety and tolerability of 274 mg ADS-5102 for LID in PD.
In an
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
UNASSIGNED
Medical treatment of levodopa-induced dyskinesia (LID) in Parkinson disease (PD) is an unmet need.
UNASSIGNED
To evaluate the efficacy and safety of ADS-5102 (amantadine) extended-release 274-mg capsules for treatment of LID in patients with PD.
UNASSIGNED
A randomized, double-blind,
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
